Outcomes following surgery for colorectal cancer with synchronous peritoneal metastases

British Journal of Surgery

Volumn 98, Issue 12, 2011, Pages 1785-1791

  Mulsow, J ^a   Merkel, S ^a   Agaimy, A ^a   Hohenberger, W ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; COLORECTAL TUMOR; FEASIBILITY STUDY; FEMALE; HUMAN; MALE; METHODOLOGY; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; MULTIPLE CANCER; PERITONEUM TUMOR; POSTOPERATIVE COMPLICATION; PROSPECTIVE STUDY; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHILD; COLORECTAL NEOPLASMS; COMBINED MODALITY THERAPY; FEASIBILITY STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS, MULTIPLE PRIMARY; PERITONEAL NEOPLASMS; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84856367754     PISSN: 00071323     EISSN: 13652168     Source Type: Journal    
DOI: 10.1002/bjs.7653     Document Type: Review

References (18)

1. Lemmens VE, Klaver YL, Verwaal VJ, Rutten HJ, Coebergh JW, de Hingh IH. Predictors and survival of synchronous peritoneal carcinomatosis of colorectal origin: A population-based study. Int J Cancer 2011; 128: 2717-2725.
2. Jayne DG, Fook S, Loi C, Seow-Choen F. Peritoneal carcinomatosis from colorectal cancer. Br J Surg 2002; 89: 1545-1550. (Pubitemid 35404323)
3. Verwaal VJ, Bruin S, Boot H, van Slooten G, van Tinteren H. 8-year follow-up of randomized trial: Cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer. Ann Surg Oncol 2008; 15: 2426-2432.
4. Elias D, Lefevre JH, Chevalier J, Brouquet A, Marchal F, Classe JM et al. Complete cytoreductive surgery plus intraperitoneal chemohyperthermia with oxaliplatin for peritoneal carcinomatosis of colorectal origin. J Clin Oncol 2009; 27: 681-685.
5. Hohenberger W, Reingruber B, Merkel S. Surgery for colon cancer. Scand J Surg 2003; 92: 45-52. (Pubitemid 36406635)
6. Hohenberger W, Merkel S, Weber K. [Lymphadenectomy with tumors of the lower gastrointestinal tract.] Chirurg 2007; 78: 217-225.
7. Hohenberger W, Weber K, Matzel K, Papadopoulos T, Merkel S. Standardized surgery for colonic cancer: Complete mesocolic excision and central ligation -technical notes and outcome. Colorectal Dis 2009; 11: 354-364.
8. Clavien PA, Barkun J, de Oliveira ML, Vauthey JN, Dindo D, Schulick RD et al. The Clavien-Dindo classification of surgical complications: Five-year experience. Ann Surg 2009; 250: 187-196.
9. Verwaal VJ, van Ruth S, de Bree E, van Sloothen GW, van Tinteren H, Boot H et al. Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. J Clin Oncol 2003; 21: 3737-3743. (Pubitemid 46606227)
10. Koppe MJ, Boerman OC, OyenWJ, Bleichrodt RP. Peritoneal carcinomatosis of colorectal origin: Incidence and current treatment strategies. Ann Surg 2006; 243: 212-222. (Pubitemid 43185440)
11. Elias D, Gilly F, Boutitie F, Quenet F, Bereder JM, Mansvelt B et al. Peritoneal colorectal carcinomatosis treated with surgery and perioperative intraperitoneal chemotherapy: Retrospective analysis of 523 patients from a multicentric French study. J Clin Oncol 2010; 28: 63-68.
12. Elias D, Raynard B, Farkhondeh F, Góeré D, Rouquie D, Ciuchendea R et al. Peritoneal carcinomatosis of colorectal origin. Gastroenterol Clin Biol 2006; 30: 1200-1204.
13. Quenet F, Góeré D, Mehta SS, Roca L, Dumont F, Hessissen M et al. Results of two bi-institutional prospective studies using intraperitoneal oxaliplatin with or without irinotecan during HIPEC after cytoreductive surgery for colorectal carcinomatosis. Ann Surg 2011; 254: 294-301.
14. Kobayashi H, Enomoto M, Higuchi T, Uetake H, Iida S, Ishikawa T et al. Validation and clinical use of the Japanese classification of colorectal carcinomatosis: Benefit of surgical cytoreduction even without hyperthermic intraperitoneal chemotherapy. Dig Surg 2010; 27: 473-480.
15. Koh JL, Yan TD, Glenn D, Morris DL. Evaluation of preoperative computed tomography in estimating peritoneal cancer index in colorectal peritoneal carcinomatosis. Ann Surg Oncol 2009; 16: 327-333.
16. Jacquet P, Sugarbaker P. Clinical research methodologies in diagnosis and staging of patients with carcinomatosis. In Peritoneal Carcinomatosis: Principles of Management, Sugarbaker PH (ed.). Kluwer Academic: Boston, 1996; 359-374.
17. Verwaal VJ, van Tinteren H, van Ruth S, Zoetmulder FA. Predicting the survival of patients with peritoneal carcinomatosis of colorectal origin treated by aggressive cytoreduction and hyperthermic intraperitoneal chemotherapy. Br J Surg 2004; 91: 739-746. (Pubitemid 38746143)
18. Yan TD, Morris DL. Cytoreductive surgery and perioperative intraperitoneal chemotherapy for isolated colorectal peritoneal carcinomatosis: Experimental therapy or standard of care? Ann Surg 2008; 248: 829-835.